期刊文献+

大肠癌HT-29细胞亚系与母系转移能力和相关因子的比较 被引量:2

Comparative analysis of metastatic variants from the colorectal tumor cell line HT-29
下载PDF
导出
摘要 目的 :探讨大肠癌细胞转移能力与肿瘤相关因素的关系。方法 :用结肠癌 HT- 2 9亚系 HT- 2 9c和 HT- 2 9d细胞在裸大鼠体内建立转移模型 ,比较其与母系的转移能力。用 ELISA法测定 3个大肠癌细胞系的尿激酶型纤溶酶原激活因子 (u PA)及纤溶酶原抑制剂 - 1(PAI- 1)含量 ;用免疫组化技术检测癌胚抗原和 3-磷酸肌醇激酶(PI3- Kinase)在体内外的表达 ;用流式细胞仪测定癌胚抗原表达。结果 :在裸鼠体内 HT- 2 9d细胞的肝转移率明显高于母系 HT- 2 9细胞 ,转移累及的脏器增多。在体外培养中 ,HT- 2 9d细胞的 u PA及 PAI- 1含量明显高于 HT- 2 9和 Wi Dr细胞。在裸鼠体内 ,HT- 2 9d细胞的 PI3- Kinase表达明显高于 HT- 2 9和 Wi Dr细胞。结论 :经裸鼠体内筛选的大肠癌 HT- 2 9细胞亚系表现出增强的肿瘤转移能力。UPA、PAI- 1的含量及 PI3- Kinase的表达与肿瘤转移能力有关。 Objective: To analyze the relationship between metastatic potential and related facters of colorectal tumor cell lines. Methods: The variants HT-29c and HT-29d cell lines derived from the selection of HT-29 cells were injected into nude rats and the metastatic potential of the two tumor cell variants was analyzed. Expression of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) were measured with ELISA in vitro in colorectal carcinoma cell lines WiDr, HT-29 and HT-29d. Expression of carcinoembryonic antigen (CEA) and phosphoinositide 3-kinase (PI3-Kinase) were determined with immunohistochemistry, (IHC) in vitro and in vivo in WiDr, HT-29 and HT-29d cell lines. In addition, CEA expression was demonstrated with fluorescence activated cell sorter (FACS) in vitro. Results: The liver metastasis rate of the variant HT-29d (with 4 cycles of selection), increased as compared with that of parental HT-29 cells and that of variant HT-29b cells (with 2 cycle of selection). The uPA concentration of variant HT-29d cell line was significantly higher than that of the non-metastatic WiDr and the low metastatic HT-29 cells ( P <0.05). The variant HT-29d cells produced stronger PI3-kinase expression as compared with the non-anetastatic WiDr cells and the low metastatic HT-29 cells in vivo. Conclusion: The selected variant cell lines can exhibit an enhanced metastatic potential. The level of uPA and PAI- 1 are positively correlated with the metastatic capacity of tumor cells. The expression of PI3-kinasecorrelates with tumor development and metastasis.
出处 《浙江大学学报(医学版)》 CAS CSCD 2002年第5期355-358,共4页 Journal of Zhejiang University(Medical Sciences)
关键词 大肠癌 HT-29细胞亚系 母系转移能力 相关因子 尿激酶 癌胚抗原 三磷酸肌醇激酶 Colorectal neoplasms Urokinase Plasminogen activator inhibitor type 1 Carcinoembryonic antigen Phosphoinositide 3-kinase
  • 相关文献

参考文献11

  • 1Vassalli J D, Sappino A P, Belin D. The plaasminogen activator/plasmin system [J]. J Clin Invest, 1991,88(4):1067-1072.
  • 2Franke T F, Kaplan D R, Cantley L C. PI3K: downstream AKTion blocks apoptosis [J]. Cell, 1997,88(4):435-437.
  • 3Vogel I, Shen Y, Soeth E, et al. A human carcinoma model in athymic rats reflecting solid and disseminated colorectal metastases [J]. Langenbeck's Arch Surg, 1998,383(6):466-473.
  • 4Morikawa K, Walker S M, Jessup J M, et al. In vivo selection of highly metastatic cell from surgical specimens of different primary human colorectal carcinomas implanted into nude mice [J]. Cancer Res, 1988,48(9):1943-1948.
  • 5Dinney C P, Fishbeck R, Singh R K, et al. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in thymic nude mice [J]. J Uro, 1995,154(4):1532-1538.
  • 6Wilhelm O, Hafter R, Henschen A, et al. Role of plasmin in the degradation of the stroma derived fibrin in human ovarian carcinoma [J]. Blood, 1990,75(8):1673-1678.
  • 7Kobayashi H, Fujishiro S, Terao T. Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus [J]. Cancer Res, 1994,54(24):6539-6548.
  • 8Grondahl-Hansen J, Christensen I J, Rosenquist C, et al. High levels of urokinase type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis [J]. Cancer Res, 1993,53(11):2513-2521.
  • 9Jessup J M, McGinnis L S, Steele G D Jr, et al. The National cancer data base report on colon cancer [J]. Cancer, 1996,78(4):918-926.
  • 10Toker A, Cantley L C. Signalling through the lipid products of phosphoinositide-3-kinase [J]. Nature, 1997,387(6634):673-676.

同被引文献7

  • 1高春芳,李冬晖,赵光,郑国宝,王秀丽,许红兵.胃癌患者血清比较蛋白质组学研究[J].解放军医学杂志,2005,30(6):457-459. 被引量:20
  • 2Werner A, Bendre E,Mahanffey W,et al. Inhibition of experimental liver metastasis by combined treatment with tamoxifen and interferon. Anticancer Drugs, 1996,7(3):307.
  • 3Merchant M, Weinberge SR. Recent advancements in surfaceenhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis, 2000, 21(6): 1164.
  • 4Emmert-Bu MR,Gillespie JW,Paweletz CP,et al. An approach to proteomic analysis of human tumors. Mol Carcinog, 2000, 27(3):158.
  • 5Davies HA.The ProteinChip System from Ciphergen:A new technique for rapid, micro-scale protein biology. J Mol Med, 2000,78(7):B29.
  • 6Werner A, Bendre E, Mahanffey W et al. Inhibition of experimental liver metastasis by combined treatment with tamoxifen and interferon.Anticancer Drugs,1996,7(3):307
  • 7赵光,高春芳,宋国英,李冬晖,王秀丽.血清中蛋白质组构型对结直肠癌的诊断意义[J].癌症,2004,23(6):614-618. 被引量:37

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部